pharmaphorum

MARCH 1, 2022

The primary care setting offers huge potential for commercial research. This was, and still is being, demonstrated through the UK’s COVID-19 vaccine research successes. But primary care site protocols can’t just be cut and pasted from hospitals. Primary care sites require their own approach, but they can have great benefits for clinical trial recruitment, access to hard-to-reach patients, and more.

Vaccines 96

Vaccines Hospitals 96

Outsourcing Pharma

MARCH 1, 2022

The company (which specializes in developing therapies for rare cancers) currently is working on a number of candidates, including its lead drug CPI-613.

98

98

pharmaphorum

MARCH 1, 2022

The US Food and Drug Administration (FDA) has approved a new cell-based therapy for blood cancer, developed by Janssen and China’s Legend Biotech to treat multiple myeloma. CARVYKTI (ciltacabtagene autoleucel), formerly known as cilta-cel, is chimeric antigen receptor T-cell (CAR-T) therapy indicated for the treatment of adults with relapsed or refractory multiple myeloma who have received four or more prior lines of therapy, including a proteasome inhibitor, an immunomodulatory agent, and

FDA 59

FDA Labelling 59

Roots Analysis

MARCH 1, 2022

The intranasal route of administration is widely accepted as effective and non-invasive option for the local and systemic delivery of several types of active pharmaceutical ingredients (API). Majority of such formulations are designed to treat chronic obstructive pulmonary disorders (COPD), asthma and other respiratory diseases. Interestingly, over the past few years, drug developers focused on non-respiratory diseases have also shifted their attention towards intranasal drug formulations.

Immunization 52

Immunization 52

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

pharmaphorum

MARCH 1, 2022

Apple pledged to make a giant impact in the healthcare industry, but Susan Lang, founder and CEO of XIL Health, says its focus on changing healthcare as a whole is an issue. . Total healthcare spending in the US increased substantially in 2020 and accounted for 19.7% of the nation’s gross domestic product. Before the pandemic, digital transformation within the health industry was progressing, but COVID accelerated digital adoption in almost every sector.

Hospitals 52

Hospitals FDA 52

Pharma Times

MARCH 1, 2022

Sensor development project marks the fifth joint research effort between BioMed X with Boehringer Ingelheim

37

37